Long-term diazoxide treatment in persistent hyperinsulinemic hypoglycemia of infancy: a patient report

J Pediatr Endocrinol Metab. 1997 Jan-Feb;10(1):79-81. doi: 10.1515/jpem.1997.10.1.79.

Abstract

Long-term diazoxide and somatostatin analogue have been used in the treatment of persistent hyperinsulinemic hypoglycemia of infancy albeit with some side effects. We report a case with persistent hyperinsulinemic hypoglycemia who has been on diazoxide therapy for 4.5 years. Diazoxide treatment maintained normoglycemia without causing any side effects, including hypertrichosis.

Publication types

  • Case Reports

MeSH terms

  • Blood Glucose / metabolism
  • Diazoxide / administration & dosage
  • Diazoxide / adverse effects
  • Diazoxide / therapeutic use*
  • Humans
  • Hyperinsulinism / complications*
  • Hypoglycemia / drug therapy*
  • Hypoglycemia / etiology*
  • Infant
  • Male

Substances

  • Blood Glucose
  • Diazoxide